// App-Quantinova.ai

: Stroke and Myocardial Infarction Risk among Newly Diagnosed Heart Failure Patients with Reduced, Borderline, and Preserved Left Ventricle Ejection Fraction

Researchers

Presenter

  • Gregg C. Fonarow

Principal Investigators

  • Eric D. Peterson

  • Barry Greenberg

  • Jeffrey S. Berger

  • Fransois Laliberte

  • Qi Zhao

  • Guillaume Germain

  • Dominique Lejeune

  • Patrick Lefebvre

Medical Centers

  • Ronald Reagan UCLA Medical Center, Los Angeles, CA

  • Duke Clinical Research Institute, Durham, NC

  • UC San Diego Health System, La Jolla, CA

  • New York University School of Medicine, New York, NY

  • Groupe d'Analyse Ltée, Montréal, Quebec, Canada

  • Janssen Scientific Affairs, LLC, Titusville, NJ

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved